UNITED STATES
                         SECURITIES EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

                Date of Report (Date of earliest event reported)
                                November 7, 2003

                              EVOLVE ONCOLOGY, INC.
                       (formerly known as Oncthera,  INC.)
             (Exact name of registrant as specified in its charter)




          DELAWARE                                   13-4047693
          --------                                   ----------
  (State  or  other  jurisdiction                    (I.R.S.  Employer
of  incorporation  or  organization)                  Identification  No.)

            151  South  Ferry  Quay
           Liverpool,  Merseyside                        L3  4EW
   --------------------------------------               -------
   (Address  of  principal  executive  offices)            (Zip  Code)


               Registrant's  telephone  number  +44  (0)  151  707  7898




ITEM  5.  OTHER  EVENTS

On  November  7th 2003, a majority of shareholders of the company voted in favor
of  changing  the  name  of  the  company  to  Evolve  Oncology  Inc.

SIGNATURES

Pursuant  to  the  requirements  of  the  Securities  Exchange  Act of 1934, the
registrant  has  duly  caused  this  report  to  be  signed on its behalf by the
undersigned  hereunto  duly  authorized.

Dated:  November  25,  2003

EVOLVE  ONCOLOGY  INC.



/s/  Ian  Warwick
- -----------------------
By:  Ian  Warwick
President